Evogene Schedules Third Quarter of 2022 Financial Results Release & Conference Call for November 17, 2022
/PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development...